IP Library Granted Patent US 8,623,623
Granted Patent B2
US 8,623,623 · App. 13/161,749 · Granted Jan 7, 2014

Xylose utilization in recombinant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,623,623
App. No.
13/161,749
Granted
Jan 7, 2014
Kind
B2
Abstract

Zymomonas expressing xylose isomerase from A. missouriensis was found to have improved xylose utilization, growth, and ethanol production when grown in media containing xylose. Xylose isomerases related to that of A. missouriensis were identified structurally through molecular phylogenetic and Profile Hidden Markov Model analyses, providing xylose isomerases that may be used to improve xylose utilization.

Claims (46)

1. A recombinant bacterial strain selected from the group consisting of Zymomonas and Zymobacter comprising a heterologous nucleic acid molecule encoding a polypeptide having xylose isomerase activity wherein the polypeptide is a Group I xylose isomerase and is included in the class of enzymes identified by EC 5.3.1.5, and wherein the strain utilizes xylose as a carbon source and wherein the heterologous nucleic acid molecule encoding a polypeptide having xylose isomerase activity is not under the control of a promoter derived from Zymomonas mobilis glyceraldehyde-3-phosphate dehydrogenase gene that has a base substitution in a position selected from the group consisting of position 116, position 217, and both position 116 and 217; wherein the position numbers are of SEQ ID NO:311; and wherein the strain demonstrates an increase in xylose utilization of between about 1.9 fold to about 17.1 fold as compared with a strain expressing a Group II xylose isomerase.

2. A recombinant bacterial strain of claim 1 wherein the polypeptide having xylose isomerase activity gives an E-value score of 1E-15 or less when queried using a Profile Hidden Markov Model prepared using SEQ ID NOs: 2, 24, 32, 34, 42, 54, 66, 68, 78, 96, 100, 106, 108, 122, 126, 128, 130, 132, 135, 137, and 142; the query being carried out using the hmmsearch algorithm wherein the Z parameter is set to 1 billion.

3. A recombinant bacterial strain of claim 1 wherein the polypeptide having xylose isomerase activity:

1) has the following conserved amino acids when compared with the reference amino acid sequence of SEQ ID NO:66:

a) leucine at position 226,

b) methionine at position 223,

c) isoleucine at position 191,

d) threonine, serine, or valine at position 195,

e) methionine, threonine or guanine at position 88,

f) histidine at position 290,

g) glutamic acid or aspartic acid at position 221,

h) phenylalanine, valine, or leucine at position 242,

i) histidine at position 243,

j) leucine, phenylalanine, or methionine at position 193,

k) glutamine at position 256,

l) glycine at position 213,

m) proline, tyrosine, alanine, or serine at position 288, and

n) glutamine at position 249; or

2) has at least 90% of the conserved amino acids of part (1).

4. A recombinant bacterial strain of claim 1 wherein the xylose isomerase has an amino acid sequence having at least 90% identity to an amino acid sequence selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, and 147 based on the Clustal W method of alignment using the default parameters of GAP PENALTY=10, GAP LENGTH PENALTY=0.1, and Gonnet 250 series of protein weight matrix.

5. A recombinant bacterial strain of claim 1 wherein the xylose isomerase is isolated from a microorganism selected from the group consisting of Actinoplanes, Arthrobacter, Streptomyces, Thermus, Thermobaculum, Herpetosiphon, Acidobacteria, Roseiflexus, Meiothermus, Deinococcus, Meiothermus, Stackebrandtia, Kribbella, Xylanimonas, Nocardiopsis, Catenulispora, Streptosporangium, Geodermatophilus, Actinosynnema, Saccharomonospora, Acidothermus, Tthermobifida, Nocardiodes, Janibacter, Mycobacterium, Leifsonia, Clavibacter, Micromonospora, Salinispora, Cellulomonas, Jonesia, Nakamurella, Actinomyces, Mobiluncus, Brachybacterium, Beutengergai, Frankia , and Actinobacterium.

6. A recombinant bacterial strain of claim 5 wherein the xylose isomerase is isolated from Actinoplanes missouriensis.

7. A recombinant bacterial strain of claim 4 wherein the Group I polypeptide having xylose isomerase activity has at least 90% identity to an amino acid sequence selected from the group consisting of SEQ ID NOs:24, 66, 134, 140, 143, 145, and 147, based on the Clustal W method of alignment using the default parameters of GAP PENALTY=10, GAP LENGTH PENALTY=0.1, and Gonnet 250 series of protein weight matrix.

8. A method for the production of ethanol comprising:

a) providing the recombinant bacterial strain of claim 1 ; and

b) contacting the strain of (a) with xylose under conditions whereby the strain produces ethanol.

9. A method according to claim 8 wherein the polypeptide having xylose isomerase activity gives an E-value score of 1E-15 or less when queried using a Profile Hidden Markov Model prepared using SEQ ID NOs: 2, 24, 32, 34, 42, 54, 66, 68, 78, 96, 100, 106, 108, 122, 126, 128, 130, 132, 135, 137, and 142; the query being carried out using the hmmsearch algorithm wherein the Z parameter is set to 1 billion.

10. A method according to claim 8 wherein the polypeptide having xylose isomerase activity:

1) has the following conserved amino acids when compared with the reference amino acid sequence of SEQ ID NO:66:

a) leucine at position 226,

b) methionine at position 223,

c) isoleucine at position 191,

d) threonine, serine, or valine at position 195,

e) methionine, threonine or guanine at position 88,

f) histidine at position 290,

g) glutamic acid or aspartic acid at position 221,

h) phenylalanine, valine, or leucine at position 242,

i) histidine at position 243,

j) leucine, phenylalanine, or methionine at position 193,

k) glutamine at position 256,

l) glycine at position 213,

m) proline, tyrosine, alanine, or serine at position 288, and

n) glutamine at position 249; or

2) has at least 90% of the conserved amino acids of part (1).

11. A method according to claim 8 wherein the xylose isomerase has an amino acid sequence having at least 90% identity to an amino acid sequence selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 2, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, and 147 based on the Clustal W method of alignment using the default parameters of GAP PENALTY=10, GAP LENGTH PENALTY=0.1, and Gonnet 250 series of protein weight matrix.

12. A method according to claim 8 wherein the xylose isomerase is isolated from a microorganism selected from the group consisting of Actinoplanes, Arthrobacter, Streptomyces, Thermus, Thermobaculum, Herpetosiphon, Acidobacteria, Roseiflexus, Meiothermus, Deinococcus, Meiothermus, Stackebrandtia, Kribbella, Xylanimonas, Nocardiopsis, Catenulispora, Streptosporangium, Geodermatophilus, Actinosynnema, Saccharomonospora, Acidothermus, Tthermobifida, Nocardiodes, janibacter, Mycobacterium, Leifsonia, Clavibacter, Micromonospora, Salinispora, Cellulomonas, jonesia, Nakamurella, Actinomyces, Mobiluncus, Brachybacterium, Beutengergai, Frankia , and Actinobacterium.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: DUPONT US HOLDING, LLC
To: SUSTAINABLE TECHNOLOGY CORPORATION
Reel/Frame 050647/0412 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DOC DATE FOR QI, MIN PREVIOUSLY RECORDED ON REEL 027042 FRAME 0109. ASSIGNOR(S) HEREBY CONFIRMS THE DOC DATE FOR INVENTOR QI, MIN SHOULD BE 09/07/2011 AND NOT 09/17/2011. Recorded Nov 14, 2011
From: KAHSAY, ROBEL Y.; QI, MIN; TAO, LUAN; VIITANEN, PAUL V.; YANG, JIANJUN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 027224/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2011
From: KAHSAY, ROBEL Y.; QI, MIN; TAO, LUAN; VIITANEN, PAUL V.; YANG, JIANJUN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 027042/0109 →